 | Up a level |
Spizzo, Gilbert; Bernardini, Karin; Pieramico, Oreste; Buratti, Thomas; Platzgummer, Stefan; Farsad, Mohsen; Schmitt, Anja M; Perren, Aurel; Vogelsang, Holger; Promegger, Rupert; Bale, Reto; Gabriel, Michael; Nevinny, Meinhard; Gastl, Guenther; Mitterer, Manfred (2011). Clinical aspects, diagnostic challenges and management of patients with neuroendocrine tumors (NETs). Onkologie, 34(3), pp. 139-46. Basel: Karger 10.1159/000324778
Ruhstaller, Thomas; Templeton, Arnoud; Ribi, Karin; Schuller, Jan C; Borner, Markus; Thierstein, Sandra; von Moos, Roger; Pederiva, Stefanie; Lohri, Andreas; Lombriser, Norbert; von Briel, Christian; Koeberle, Dieter; Popescu, Razvan (2010). Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02). Onkologie, 33(5), pp. 222-8. Basel: Karger 10.1159/000305094
Klaeser, Bernd; Nitzsche, Egbert; Schuller, Jan C; Köberle, Dieter; Widmer, Lucas; Balmer-Majno, Sabine; Hany, Thomas; Cescato-Wenger, Corinne; Brauchli, Peter; Zünd, Michael; Pestalozzi, Bernhard C; Caspar, Clemens; Albrecht, Susanne; von Moos, Roger; Ruhstaller, Thomas (2009). Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02). Onkologie, 32(12), pp. 724-30. Basel: Karger 10.1159/000251842
Cerny, David; Cerny, Thomas; Ess, Silvia; D'Addario, Giannicola; Früh, Martin (2009). Lung cancer in the Canton of St. Gallen, Eastern Switzerland: sex-associated differences in smoking habits, disease presentation and survival. Onkologie, 32(10), pp. 569-573. Karger 10.1159/000232581
Salzberg, Marc; Rochlitz, Christoph; Morant, Rudolf; Thalmann, George; Pedrazzini, Augusto; Roggero, Enrico; Schönenberger, Astrid; Knuth, Alexander; Borner, Markus (2007). An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer. Onkologie, 30(7), pp. 355-60. Basel: Karger 10.1159/000102452
Wolter, I; Baerlocher, GM (2007). Chronische Myeloische Leukämie: Epidemiologie, Pathogenese, Symptomatik, Diagnostik und Therapie der CML. Onkologie(1), pp. 14-19. Basel: Karger
Schmidt, A; Solenthaler, M (2007). Chronische lymphatische Leukämie: Einteilung, Verlauf, Therapie und Prognose der CLL. Onkologie(1), pp. 20-9. Basel: Karger
von Rohr, L; Klaeser, B; Joerger, M; Kluckert, T; Cerny, T; Gillessen, S (2007). Increased pulmonary FDG uptake in bleomycin-associated pneumonitis. Onkologie, 30(6), pp. 320-3. Basel: Karger 10.1159/000101517
Hess, D; Koberle, D; Thurlimann, B; Pagani, O; Schonenberger, A; Mattmann, S; Rochlitz, C; Rauch, D; Schuller, J C; Ballabeni, P; Ribi, K (2007). Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99). Onkologie, 73(3-4), pp. 228-37. Basel: Karger 10.1159/000180915
